Zdrowie i gospodarka · 16/11/2020

FDA Requests Public Comment on Proposed Collection of Information for New Drug Approval

The Food and Drug Administration (FDA) is seeking public input on its proposed collection of information related to applications for FDA approval to market a new drug, as required by the Paperwork Reduction Act of 1995.